ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Jupiter Neurosciences Inc

Jupiter Neurosciences Inc (JUNS)

0.00
0.00
(0.00%)
Closed February 28 04:00PM
0.00
0.00
(0.00%)

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
-
Bid
-
Ask
-
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Previous Close
-
Open
-
Last Trade
Last Trade Time
Average Volume (3m)
-
Financial Volume
-
VWAP
-

JUNS Latest News

No news to show yet.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
JANXJanux Therapeutics Inc
$ 49.75
(229.47%)
15.49M
SZZLUSizzle Acquisition Corporation
$ 20.88
(122.13%)
1.53k
VKTXViking Therapeutics Inc
$ 85.05
(121.02%)
59.03M
SZZLSizzle Acquisition Corporation
$ 22.12
(116.86%)
53.58k
CXAICXApp Inc
$ 2.82
(81.94%)
100.18M
NERVMinerva Neurosciences Inc
$ 2.8001
(-58.82%)
1.95M
IFBDInfobird Company Ltd
$ 1.28
(-53.62%)
55.53M
NRXPNRX Pharmaceuticals Inc
$ 0.2991
(-30.05%)
6.62M
TWKSThoughtworks Holding Inc
$ 3.275
(-28.96%)
4.88M
STGWStagwell Inc
$ 5.26
(-25.07%)
2.08M
SOUNSoundHound AI Inc
$ 6.86
(19.30%)
301.42M
GOEVCanoo Inc
$ 0.1138
(8.28%)
118.88M
MARAMarathon Digital Holdings Inc
$ 30.31
(3.84%)
116.94M
NKLANikola Corporation
$ 0.7558
(4.57%)
111M
TSLATesla Inc
$ 199.73
(0.17%)
108.68M

JUNS Discussion

View Posts
Invest-in-America Invest-in-America 1 year ago
JUNS (IPO):
👍️0
makinezmoney makinezmoney 1 year ago
$JUNS: IPO is launching next week

We are waiting on it.



Jupiter Neurosciences, Inc. has developed the first and only resveratrol product that safely reaches therapeutic levels without GI-side effects creating treatment possibilities in many indications.

https://jupiterneurosciences.com/








GO $JUNS
👍️0
Invest-in-America Invest-in-America 1 year ago
JUNS: Evidently, now ready-to-go on E-Turd, Fidelity, etc.
👍️0
spindog spindog 2 years ago
Ticker hasn’t shown up on E*TRADE yet
👍️0
crudeoil24 crudeoil24 2 years ago
IPO scheduled for February 3, 2022.
👍️0
crudeoil24 crudeoil24 2 years ago
Jupiter Neurosciences, Inc., a clinical stage research and development pharmaceutical company, develops resveratrol platform product primarily for the treatment of neuro-inflammation. It is developing JNS101 that is in Phase II trials for the treatment of Friedreich's Ataxia, a rare disease that causes damage to the nervous system, as well as mobility dysfunctions; and JNS102, which is in Phase II trials for the treatment of mucopolysaccharidosis Type I. The company is also developing JNS107 that is in Phase II trials for the treatment of MELAS Syndrome; and JNS108, which is in Phase II trials for the treatment of mild cognitive impairment/early Alzheimer’s disease. In addition, it is developing JNS109 for amyotrophic lateral sclerosis; JNS110 for traumatic brain injury/concussion; and JNS120 for covid-19 treatment. The company was formerly known as Jupiter Orphan Therapeutics, Inc. and changed its name to Jupiter Neurosciences, Inc. in August 2021. The company was founded in 2016 and is headquartered in Jupiter, Florida.
👍️0

Your Recent History

Delayed Upgrade Clock

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 | help@advfn.com